Association between coronary artery vitamin D receptor expression and select systemic risks factors for coronary artery atherosclerosis

References

• Teichert AE, Elalieh H, Elias PM, et al. Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice. J Invest Dermatol. 2011;131(11):2289–2297.
   PubMed Web of Science ®Google Scholar
• McGreevy C, Williams D. New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med. 2011;155(12):820–826.
   PubMed Web of Science ®Google Scholar
• Adams JS, Ren S, Liu PT, et al. Vitamin D-directed rheostatic regulation of monocyteantibacterial responses. J Immunol. 2009;182(7):4289–4295.
   PubMed Web of Science ®Google Scholar
• Liu NQ, Hewison M. Vitamin D, the placenta and pregnancy. Arch Biochem Biophys. 2012;523(1):37–47.
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004;79(3):362–371.
   PubMed Web of Science ®Google Scholar
• Melamed ML, Muntner P, Michos ED, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. ATVB. 2008;28(6):1179–1185.
   Google Scholar
• Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol. 2006;65(5):593–597.
   PubMed Web of Science ®Google Scholar
• de Boer IH, Kestenbaum B, Shoben AB, et al. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. JASN. 2009;20(8):1805–1812.
   Web of Science ®Google Scholar
• Schnatz PF, Nudy M, O'Sullivan DM, et al. Identification of a mechanism for increased cardiovascular risk among individuals with low vitamin D concentrations. Menopause. 2011;18(9):994–1000.
   PubMed Web of Science ®Google Scholar
• Chen S, Glenn DJ, Ni W, et al. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension. 2008;52(6):1106–1112.
   PubMed Web of Science ®Google Scholar
• Stumpf WE, Sar M, Reid FA, et al. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science. 1979;206(4423):1188–1190.
   PubMed Web of Science ®Google Scholar
• Schnatz PF, Nudy M, O’Sullivan DM, et al. The quantification of vitamin D receptors in coronary arteries and their association with atherosclerosis. Maturitas. 2012;73(2):143–147.
   PubMed Web of Science ®Google Scholar
• Schnatz PF, Nudy M, O’Sullivan DM, et al. Coronary artery vitamin D receptor expression and plasma concentrations of 25-hydroxyvitamin D: their association with atherosclerosis. Menopause. 2012;19(9):967–973.
   PubMed Web of Science ®Google Scholar
• Chen S, Law CS, Gardner DG. Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity. J Steroid Biochem Mol Biol. 2010;118(3):135–141.
   PubMed Web of Science ®Google Scholar
• Li YC, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89-90(1-5):387–392.
   PubMed Web of Science ®Google Scholar
• Rostkowska-Nadolska B, Sliupkas-Dyrda E, Potyka J, et al. Vitamin D derivatives: calcitriol and tacalcitol inhibits interleukin-6 and interleukin-8 expression in human nasal polyp fibroblast cultures. Adv Med Sci. 2010;55(1):86–92.
   PubMed Web of Science ®Google Scholar
• Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002;95(12):787–796.
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Woodward WD, Hayes CE, et al. 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol. 1998;160(11):5314–5319.
   PubMed Web of Science ®Google Scholar
• Molinari C, Uberti F, Grossini E, et al. 1α,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem. 2011;27(6):661–668.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836–843.
   PubMed Web of Science ®Google Scholar
• Rose G, Shipley M. Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study. Br Med J (Clin Res Ed). 1986;293(6542):306–307.
   PubMedGoogle Scholar
• Register TC, Cann JA, Kaplan JR, et al. Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab. 2005;90(3):1734–1740.
   PubMed Web of Science ®Google Scholar
• Meléndez GC, Register TC, Appt SE, et al. Beneficial effects of soy supplementation on postmenopausal atherosclerosis are dependent on pretreatment stage of plaque progression. Menopause. 2015;22(3):289–296.
   PubMed Web of Science ®Google Scholar
• Stork S, Baumann K, von Schacky C, et al. The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women. Cardiovasc Res. 2002;53:642–649.
   PubMed Web of Science ®Google Scholar
• Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effect of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab. 2001;86(1):41–47.
   PubMed Web of Science ®Google Scholar
• Detre S, Saclani Jotti G, Dowsett M. A “quickscore” method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol. 1995;48(9):876–878.
   PubMed Web of Science ®Google Scholar
• van Diest PJ, Weger DR, Lindholm J. Reproducibility of subjective immunoscoring of steroid receptors in breast cancer. Anal Quant Cytol Histol. 1996;18(5):351–354.
   PubMedGoogle Scholar
• Weigert C. ber eine Methode zur Farbung elastischer Fasern. Zentralblatt fur Allgemeine Patholgi, und Pathologische Anatomie 1898;9:289–292.
   Google Scholar
• Siboni A, Mourits-Andersen T, Moesner J. Granulomatous bone marrow inflammation during treatment of chronic myeloid leukaemia with interferon alpha-2b. J Clin Pathol. 1995;48(9):878–880.
   PubMed Web of Science ®Google Scholar
• Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta. 2010;411(21–22):1570–1579.
   PubMed Web of Science ®Google Scholar
• Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol. 2008;28(11):1897–1908.
   PubMed Web of Science ®Google Scholar
• de Lemos JA, Morrow DA, Sabatine MS, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003;107(5):690–695.
   PubMed Web of Science ®Google Scholar
• Walker SE, Register TC, Appt SE, et al. Plasma lipid-dependent and -independent effects of dietary soy protein and social status on atherogenesis in premenopausal monkeys: implications for postmenopausal atherosclerosis burden. Menopause. 2008;15(5):950–957.
   Google Scholar
• Walker SE, Adams MR, Franke AA, Register TC. Effects of dietary soy protein on iliac and carotid artery atherosclerosis and gene expression in male monkeys. Atherosclerosis. 2008;196(1):106–113.
   Google Scholar
• Inadera H, Egashira K, Takemoto M, et al. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res. 1999;19(10):1179–1182.
   PubMed Web of Science ®Google Scholar
• Seli E, Pehlivan T, Selam B, et al. Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil Steril. 2002;77(3):542–547.
   PubMed Web of Science ®Google Scholar
• Seli E, Selam B, Mor G, et al. Estradiol regulates monocyte chemotactic protein-1 in human coronary artery smooth muscle cells: a mechanism for its antiatherogenic effect. Menopause. 2001;8:296–301.
   PubMed Web of Science ®Google Scholar
• Barbarawi M, Kheiri B, Zayed Y, et al. Vitamin D supplementation and cardiovascular disease risks in more than 83 000 individuals in 21 randomized clinical trials: a Meta-analysis. JAMA Cardiol. 2019;4(8):765–776.
   PubMed Web of Science ®Google Scholar